drugset / Trial / NCT04290572
Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized clinical trial to compare the efficacy of different doses of oral isotretinoin 10 mg/day, 20 mg/day and 30 mg/day during 12 weeks for the treatment of facial recalcitrant flat warts. The primary endpoint will be the proportion of participants with total remission of facial flat warts at the end of the intervention in the three arms of the clinical trial.
Timeline
- Start
- 2020-03-15
- Primary completion
- 2023-02-28
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isotretinoin | Other / unclassified | 10 mg | Oral |
| Subject | Isotretinoin | Other / unclassified | 20 mg | Oral |
| Subject | Isotretinoin | Other / unclassified | 30 mg | Oral |